Authors : Muhammad Ahsan; Azra Bashir; Ghazi Zafar; Anum Khan; Akhtar Sohail Chughtai; Aribah Atiq

Volume/Issue : Volume 9 - 2024, Issue 10 - October

Google Scholar : https://tinyurl.com/knfn82kz

Scribd : https://tinyurl.com/mw74wudt

DOI : https://doi.org/10.38124/ijisrt/IJISRT24OCT424

Abstract : Objective: Among prostate cancer patients, the Gleason score is associated with adverse clinical outcomes. We aimed to determine whether cribriform architecture in prostate cancer patients without a history of treatment was related to prognosis in patients with Gleason pattern 4 of prostate cancer.  Material and Methods: A prospective cross-sectional study included (n=450) consecutive prostate biopsy specimens between June 2014 and May 2015, out of which (n=237) had pattern 4 prostate adenocarcinoma. Demographic, clinical, and follow-up details were obtained. Patients (n = 86) with a treatment history were excluded from the study.  Results: Univariate Cox regression analysis of diagnostic biopsies from (n=151) patients with pattern 4 of prostate cancer who had been followed for an average of 70.3 months demonstrated that the cribriform architecture of prostate cancer with pattern 4 was independently associated with poorer disease-specific survival in biopsies with a hazard ratio (HR) of 3.1, 95% Confidence Interval (CI) of 0.9-10.6, and P value of <0.001.  Conclusion: It is concluded that a cribriform architecture of prostate cancer in biopsies with pattern 4 adenocarcinoma is associated with a lower disease- specific survival rate. Therefore, it is essential to report the presence and percentage of cribriform architecture in patients with pattern 4 prostate cancer.

Keywords : Prostate Cancer, Gleason Score, Cribriform Architecture, Prognosis, Prostatic Adenocarcinoma.

References :

1. Wang, L., Lu, B., He, M., Wang, Y., Wang, Z., & Du, L. (2022). Prostate Cancer Incidence and Mortality: Global Status and Temporal Trends in 89 Countries From 2000 to 2019. Frontiers in Public Health, 10.
2. Akhtar, S., Hassan, F., Ahmad, S., El-Affendi, M. A., & Khan, M. I. (2023). The prevalence of prostate cancer in Pakistan: A systematic review and meta-analysis. Heliyon, 9(10).
3. Martin, N. E., Mucci, L. A., Loda, M., & DePinho, R. A. (2011). Prognostic Determinants in Prostate Cancer. Cancer Journal (Sudbury, Mass.), 17(6), 429.
4. Gordetsky J, Epstein J. Grading of prostatic adenocarcinoma: current state and prognostic implications. Diagn Pathol. 2016;11:25. Published 2016 Mar 9.
5. van Leenders GJLH, van der Kwast TH, Grignon DJ, et al. The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma. Am J Surg Pathol. 2020;44(8):e87-e99.
6. Shah RB, Cai Q, Aron M, et al. Diagnosis of "cribriform" prostatic adenocarcinoma: an interobserver reproducibility study among urologic pathologists with recommendations. Am J Cancer Res. 2021;11(8):3990-4001. Published 2021 Aug 15.
7. Surintrspanont J, Zhou M. Prostate Pathology: What is New in the 2022 WHO Classification of Urinary and Male Genital Tumors?. Pathologica. 2022;115(1):41-56.
8. Greenland NY, Cowan JE, Zhang L, et al. Expansile cribriform Gleason pattern 4 has histopathologic and molecular features of aggressiveness and greater risk of biochemical failure compared to glomerulation Gleason pattern 4. Prostate. 2020;80(8):653-659.
9. Sayan M, Tuac Y, Akgul M, et al. Prognostic Significance of the Cribriform Pattern in Prostate Cancer: Clinical Outcomes and Genomic Alterations. Cancers (Basel). 2024;16(7):1248. Published 2024 Mar 22.
10. Oufattole J, Dey T, D'Amico AV, van Leenders GJLH, Acosta AM. Cribriform morphology is associated with higher risk of biochemical recurrence after radical prostatectomy in patients with Grade Group 5 prostate cancer. Histopathology. 2023;82(7):1089-1097. doi:10.1111/his.14901
11. Okubo Y, Sato S, Hasegawa C, et al. Cribriform pattern and intraductal carcinoma of the prostate can have a clinicopathological impact, regardless of their percentage and/or number of cores. Hum Pathol. 2023;135:99-107.
12. Choy B, Pearce SM, Anderson BB, et al. Prognostic Significance of Percentage and Architectural Types of Contemporary Gleason Pattern 4 Prostate Cancer in Radical Prostatectomy. Am J Surg Pathol. 2016;40(10):1400-1406.
13. Greenland NY, Cowan JE, Stohr BA, Simko JP, Carroll PR, Chan E. Large cribriform glands (> 0.25 mm diameter) as a predictor of adverse pathology in men with Grade Group 2 prostate cancer. Histopathology. 2024;84(4):614-623.
14. Chen Z, Pham H, Abreu A, et al. Prognostic value of cribriform size, percentage, and intraductal carcinoma in Gleason score 7 prostate cancer with cribriform Gleason pattern 4. Hum Pathol. 2021;118:18-29.
15. Choy B, Pearce SM, Anderson BB, et al. Prognostic Significance of Percentage and Architectural Types of Contemporary Gleason Pattern 4 Prostate Cancer in Radical Prostatectomy. Am J Surg Pathol. 2016;40(10):1400-1406.
16. Hollemans E, Verhoef EI, Bangma CH, et al. Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis. Mod Pathol. 2019;32(1):139-146. doi:10.1038/s41379-018-0157-9
17. Kweldam CF, Kümmerlin IP, Nieboer D, et al. Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy. Mod Pathol. 2016;29(6):630-636.